Veterinary Neurodegenerative Disease Diagnostics Market To Reach $596.1 Million By 2030

Veterinary Neurodegenerative Disease Diagnostics Market Growth & Trends

The global veterinary neurodegenerative disease diagnostics market size is anticipated to reach USD 596.1 million by 2030 and is projected to grow at a CAGR of 8.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. Several factors are responsible for the market growth.

Firstly, the rising pet ownership globally has increased demand for advanced veterinary care, including neurodegenerative diagnostics and treatments. Secondly, the growing awareness among pet owners about age-related neurological conditions, such as canine cognitive dysfunction, is driving early diagnosis and intervention. Thirdly, advancements in veterinary imaging and biomarker diagnostics are enabling accurate and non-invasive detection of neurodegenerative diseases. In addition, increased research and development activities in veterinary neuroscience, along with the availability of novel therapeutics and neuroprotective drugs, are expanding treatment options. The trend of pet humanization, where animals are treated as family members, further encourages spending on specialized healthcare services. Lastly, supportive government and private initiatives to improve animal health infrastructure and services are also boosting market growth.

The increasing number of veterinarians contributes significantly to the market by expanding access to specialized care and early diagnosis of neurological disorders in animals. For instance, according to AVMA, the number of veterinarians increased to 130,415 in 2024 from 127,131 in 2023. As more veterinary professionals enter the field, especially those trained in neurology, the availability of advanced services such as neuroimaging, biomarker testing, and tailored treatment plans rises. This not only improves the quality of care but also boosts pet owners' confidence in seeking early medical attention for symptoms like seizures, behavioral changes, or mobility issues. Moreover, a larger veterinary workforce facilitates the adoption of cutting-edge technologies and therapies, thereby accelerating market expansion through enhanced service capacity and outreach.

Moreover, strategic initiatives by key players are significantly driving the market growth by fostering innovation, expanding market reach, and improving diagnostic capabilities. For instance, in October 2024, WOORIEN Co., Ltd, a specialist in veterinary imaging equipment and solutions, launched 'MyVet CT Plus.' Designed to accommodate a wide range of animal sizes from small lizards to large retrievers, MyVet CT Plus offers significantly faster imaging with improved quality. Compared to its predecessor, it reduces acquisition time by at least 45%, with potential reductions of up to 80%.

 Request a free sample copy or view report summary: Veterinary Neurodegenerative Disease Diagnostics Market Report

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights

• The consumables, reagents, and kits segment accounted for the largest market revenue share in 2024. These products support veterinarians in conducting advanced molecular and biochemical tests, which are essential for diagnosing complex neurodegenerative diseases that are challenging to identify based solely on clinical symptoms.

• The companion segment dominated accounted for the largest market revenue share in 2024. This segment is also anticipated to grow at the fastest CAGR over the forecast period.

• The imaging segment accounted for the largest market revenue share in 2024, driven by its vital role in the early and accurate diagnosis of neurological disorders in animals.

• The cognitive dysfunction segment led the market with the largest revenue share of 40.35% in 2024, driven by its high prevalence in companion animals and the critical need for rapid and accurate detection to prevent outbreaks.

• Veterinary hospitals and clinics hold a dominant position in the global market, as they are the primary locations where animals receive their initial assessment and diagnosis.

• North America dominated the market with the largest revenue share of 38.25% in 2024, while the Asia Pacific region is projected to experience at the fastest CAGR during the forecast period.

Veterinary Neurodegenerative Disease Diagnostics Market Segmentation

Grand View Research has segmented the global veterinary neurodegenerative disease diagnostics market based on the animal type, product, diagnostic tests, indication, end use, and region.

Veterinary Neurodegenerative Disease Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables, Reagents & Kits

• Equipment & Instruments

Veterinary Neurodegenerative Disease Diagnostics Diagnostic Tests Outlook (Revenue, USD Million, 2018 - 2030)

• Imaging

  • MRI (Magnetic Resonance Imaging)

  • CT (Computed Tomography)

  • Others

• Biomarker Diagnostic Tests

  • CSF (Cerebrospinal Fluid) biomarkers

  • Blood-based biomarkers

  • Others

• Others

Veterinary Neurodegenerative Disease Diagnostics Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Livestock

  • Sheep

  • Cattle

  • Others

• Companion

  • Canine

  • Feline

  • Equine

  • Others

Veterinary Neurodegenerative Disease Diagnostics Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Cognitive Dysfunction

• Cerebellar Abiotrophy

• Spongiform Encephalopathies

• Others

Veterinary Neurodegenerative Disease Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Veterinary Hospitals and Clinics

• Veterinary Diagnostic Laboratories

• Others

Veterinary Neurodegenerative Disease Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Veterinary Neurodegenerative Disease Diagnostics Market

• Zoetis

• Virbac

• Life Diagnostics

• ACUVET BIOTECH

• Merck & Co., Inc.

• IDEXX Laboratories, Inc.

• MI:RNA Diagnostics Ltd.

• Mercodia AB

• Antech Diagnostics, Inc.

• Avacta Animal Health Limited